Propionibacterium-produced coproporphyrin III induces staphylococcus aureus aggregation and Biofilm formation

mBio

Volumn 5, Issue 4, 2014, Pages 1-10

  Wollenberg, Michael S ^a,b,e   Claesen, Jan ^c   Escapa, Isabel F ^a,b   Aldridge, Kelly L ^a,f   Fischbach, Michael A ^c   Lemon, Katherine P ^a,d  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e KALAMAZOO COLLEGE   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPROPORPHYRIN; COPROPORPHYRIN III; UNCLASSIFIED DRUG; CULTURE MEDIUM;

ADULT; ARTICLE; BACTERIAL AGGREGRATION; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; HUMAN; NONHUMAN; ORGANISMAL INTERACTION; PH; PROPIONIBACTERIUM; STAPHYLOCOCCUS AUREUS; CULTURE MEDIUM; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PHARMACOLOGY;

PROPIONIBACTERIUM; STAPHYLOCOCCUS AUREUS;

BIOFILMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPROPORPHYRINS; CULTURE MEDIA, CONDITIONED; PROPIONIBACTERIUM; STAPHYLOCOCCUS AUREUS;

EID: 84908290065     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01286-14     Document Type: Article

References (63)

1. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620-625. http://dx.doi.org/10.1038/nature07008.
2. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC. 2006. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J. Infect. Dis. 193:172-179. http://dx.doi.org/10.1086/499632.
3. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis. 197:1226-1234. http://dx.doi.org/10.1086/533494.
4. McShane D, Davies JC, Davies MG, Bush A, Geddes DM, Alton EW. 2003. Airway surface pH in subjects with cystic fibrosis. Eur. Respir. J. 21:37-42. http://dx.doi.org/10.1183/09031936.03.00027603.
5. Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. 2000. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int. J. Pharm. 198:139-146. http://dx.doi.org/10.1016/S0378-5173(99)00442-1.
6. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190-1192. http://dx.doi.org/10.1126/science.1171700.
7. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. 2009. Bacterial community variation in human body habitats across space and time. Science 326:1694-1697. http://dx.doi.org/10.1126/science.1177486.
8. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, Kolter R. 2010. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. mBio 1(3):e00129-00110. http://dx.doi.org/10.1128/mBio.00129-10.
9. Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. 2010. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One 5:e10598. http://dx.doi.org/10.1371/journal.pone.0010598.
10. Wos-Oxley ML, Plumeier I, von Eiff C, Taudien S, Platzer M, Vilchez-Vargas R, Becker K, Pieper DH. 2010. A poke into the diversity and associations within human anterior nare microbial communities. ISME J. 4:839-851. http://dx.doi.org/10.1038/ismej.2010.15.
11. HMP Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207-214. http://dx.doi.org/10.1038/nature11234.
12. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762. http://dx.doi.org/10.1016/S1473-3099(05)70295-4.
13. Kluytmans JA, Mouton JW, Ijzerman EP, Vandenbroucke-Grauls CM, Maat AW, Wagenvoort JH, Verbrugh HA. 1995. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171:216-219. http://dx.doi.org/10.1093/infdis/171.1.216.
14. Luzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, Wone C, Knefati Y, Kessler M, Peluso F. 1990. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N. Engl. J. Med. 322:505-509. http://dx.doi.org/10.1056/NEJM199002223220804.
15. Nouwen J, Schouten J, Schneebergen P, Snijders S, Maaskant J, Koolen M, van Belkum A, Verbrugh HA. 2006. Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J. Clin. Microbiol. 44:2233-2236. http://dx.doi.org/10.1128/JCM.02083-05.
16. von Eiff C, Becker K, Machka K, Stammer H, Peters G. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N. Engl. J. Med. 344 : 11-16. http ://dx.doi.org/10.1056/NEJM200101043440102.
17. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers. Lancet 364:703-705. http://dx.doi.org/10.1016/S0140-6736(04)16897-9.
18. CDC. 2005-2011. Active bacterial core surveillance Report, emerging infections program network, methicillin-resistant Staphylococcus aureus. CDC, Atlanta, GA. http://www.cdc.gov/abcs/reports-findings/surv-reports.html.
19. Proctor RA. 2012. Challenges for a universal Staphylococcus aureus vaccine. Clin. Infect. Dis. 54:1179-1186. http://dx.doi.org/10.1093/cid/cis033.
20. Jansen KU, Girgenti DQ, Scully IL, Anderson AS. 2013. Vaccine review: “Staphyloccocus aureus vaccines: problems and prospects.” Vaccine 31: 2723-2730. http://dx.doi.org/10.1016/j.vaccine.2013.04.002.
21. Schaller M, Loewenstein M, Borelli C, Jacob K, Vogeser M, Burgdorf WH, Plewig G. 2005. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br. J. Dermatol. 153:66-71. http://dx.doi.org/10.1111/j.1365-2133.2005.06530.x.
22. Borelli C, Merk K, Schaller M, Jacob K, Vogeser M, Weindl G, Berger U, Plewig G. 2006. In vivo porphyrin production by P. Acnes in untreated acne patients and its modulation by acne treatment. Acta Derm. Venereol. 86:316-319. http://dx.doi.org/10.2340/00015555-0088.
23. Heinemann IU, Jahn M, Jahn D. 2008. The biochemistry of heme biosynthesis. Arch. Biochem. Biophys. 474:238-251. http://dx.doi.org/10.1016/j.abb.2008.02.015.
24. Cavallaro G, Decaria L, Rosato A. 2008. Genome-based analysis of heme biosynthesis and uptake in prokaryotic systems. J. Proteome Res. 7:4946-4954. http://dx.doi.org/10.1021/pr8004309.
25. Panek H, O’Brian MR. 2002. A whole genome view of prokaryotic haem biosynthesis. Microbiology 148:2273-2282.
26. Leeper FJ. 1989. The biosynthesis of porphyrins, chlorophylls, and vitamin B12. Nat. Prod. Rep. 6:171-203. http://dx.doi.org/10.1039/np9890600171.
27. Clardy J, Fischbach MA, Walsh CT. 2006. New antibiotics from bacterial natural products. Nat. Biotechnol. 24:1541-1550. http://dx.doi.org/10.1038/nbt1266.
28. Baltz RH. 2008. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharmacol. 8:557-563. http://dx.doi.org/10.1016/j.coph.2008.04.008.
29. Lee WL, Shalita AR, Poh-Fitzpatrick MB. 1978. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum. J. Bacteriol. 133:811-815.
30. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J, Anderson KL, Dunman PM, Joyce S, Skaar EP. 2007. A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe 1:109-119. http://dx.doi.org/10.1016/j.chom.2007.03.001.
31. Liquori AM, Monroy A, Parisi E, Tripiciano A. 1981. A theoretical equation for diauxic growth and its application to the kinetics of the early development of the sea urchin embryo. Differentiation 20:174-175. http://dx.doi.org/10.1111/j.1432-0436.1981.tb01173.x.
32. Scolaro LM, Castriciano M, Romeo A, Patane S, Cefalo E, Allegrini M. 2002. Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation. J. Phys. Chem. B 106:2453-2459. http://dx.doi.org/10.1021/jp013155h.
33. Otto M. 2008. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322:207-228.
34. Cassat JE, Smeltzer MS, Lee CY. 2014. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol. Biol. 1085:-195-211. http://dx.doi.org/10.1007/978-1-62703-664-1_12.
35. Beenken KE, Blevins JS, Smeltzer MS. 2003. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect. Immun. 71:4206-4211. http://dx.doi.org/10.1128/IAI.71.7.4206-4211.2003.
36. Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, Penadés JR, Lasa I. 2003. SarA and not SigmaB is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48:1075-1087. http://dx.doi.org/10.1046/j.1365-2958.2003.03493.x.
37. Cheung AL, Nishina KA, Trotonda MP, Tamber S. 2008. The SarA protein family of Staphylococcus aureus. Int. J. Biochem. Cell Biol. 40: 355-361. http://dx.doi.org/10.1016/j.biocel.2007.10.032.
38. Lo CW, Lai YK, Liu YT, Gallo RL, Huang CM. 2011. Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting beta-hemolysin and CAMP factor. J. Invest. Dermatol. 131: 401-409. http://dx.doi.org/10.1038/jid.2010.319.
39. Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, Gallo RL, Huang CM. 2013. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillinresistant Staphylococcus aureus. PLoS One 8:e55380. http://dx.doi.org/10.1371/journal.pone.0055380.
40. Cornelius CE, III, Ludwig GD. 1967. Red fluorescence of comedones: production of porphyrins by Corynebacterium acnes. J. Invest. Dermatol. 49:368-370. http://dx.doi.org/10.1038/jid.1967.54.
41. Anttila J, Heinonen P, Nenonen T, Pino A, Iwaï H, Kauppi E, Soliymani R, Baumann M, Saksi J, Suni N, Haltia T. 2011. Is coproporphyrin III a copper-acquisition compound in Paracoccus denitrificans? Biochim. Biophys. Acta 1807 : 311-318.http ://dx. doi.org/10.10 1 6/j.bbabio.2010.12.014.
42. Marsili E, Baron DB, Shikhare ID, Coursolle D, Gralnick JA, Bond DR. 2008. Shewanella secretes flavins that mediate extracellular electron transfer. Proc. Natl. Acad. Sci. U. S. A. 105:3968-3973. http://dx.doi.org/10.1073/pnas.0710525105.
43. von Canstein H, Ogawa J, Shimizu S, Lloyd JR. 2008. Secretion of flavins by Shewanella species and their role in extracellular electron transfer. Appl. Environ. Microbiol. 74:615-623. http://dx.doi.org/10.1128/AEM.01387-07.
44. Clarke TA, Edwards MJ, Gates AJ, Hall A, White GF, Bradley J, Reardon CL, Shi L, Beliaev AS, Marshall MJ, Wang Z, Watmough NJ, Fredrickson JK, Zachara JM, Butt JN, Richardson DJ. 2011. Structure of a bacterial cell surface decaheme electron conduit. Proc. Natl. Acad. Sci. U. S. A. 108:9384-9389. http://dx.doi.org/10.1073/pnas.1017200108.
45. Brüggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, Strittmatter A, Hujer S, Dürre P, Gottschalk G. 2004. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305:671-673. http://dx.doi.org/10.1126/science.1100330.
46. López D, Vlamakis H, Kolter R. 2010. Biofilms. Cold Spring Harb. Perspect.Biol.2:a000398. http://dx.doi.org/10.11 0 1/cshperspect.a000398.
47. Anderson GG, O’Toole GA. 2008. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol. 322:85-105. http://dx.doi.org/10.1007/978-3-540-75418-3_5.
48. Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen IL, Bayles KW, Horswill AR, Kielian T. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186:6585-6596. http://dx.doi.org/10.4049/jimmunol.1002794.
49. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. 2012. The application of ecological theory toward an understanding of the human microbiome. Science 336:1255-1262. http://dx.doi.org/10.1126/science.1224203.
50. Lindsay JA, Riley TV. 1994. Staphylococcal iron requirements, siderophore production, and iron-regulated protein expression. Infect. Immun. 62:2309-2314.
51. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56. http://dx.doi.org/10.1016/0003-2697(87)90612-9.
52. Neubauer M, Šourek J, Rýc M, Boháček J, Mára M, Mnǔková J. 1991. Corynebacterium accolens sp. nov., a Gram-positive rod exhibiting satellitism, from clinical material. Syst. Appl. Microbiol. 14:46-51. http://dx.doi.org/10.1016/S0723-2020(11)80360-7.
53. Blattner FR, Plunkett G, III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y. 1997. The complete genome sequence of Escherichia coli K-12. Science 277: 1453-1462. http://dx.doi.org/10.1126/science.277.5331.1453.
54. Moore WEC, Holdeman LV. 1970. In Cato EP, Cummins CS, Holdeman LV, Johnson JL, Moore WEC, Smibert RM, Smith LD (ed), Outline of clinical methods in anaerobic bacteriology. Virginia Polytechnic Institute, Anaerobe Laboratory, Blacksburg, VA.
55. Johnson JL, Cummins CS. 1972. Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica. J. Bacteriol. 109: 1047-1066.
56. Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL, Smeltzer MS. 1995. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect. Immun. 63:3373-3380.
57. Blevins JS, Beenken KE, Elasri MO, Hurlburt BK, Smeltzer MS. 2002. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect. Immun. 70:470-480. http://dx.doi.org/10.1128/IAI.70.2.470-480.2002.
58. Goetz MB, Mulligan ME, Kwok R, O’Brien H, Caballes C, Garcia JP. 1992. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus. Am. J. Med. 92:607-614. http://dx.doi.org/10.1016/0002-9343(92)90778-A.
59. Tenover FC, Arbeit R, Archer G, Biddle J, Byrne S, Goering R, Hancock G, Hébert GA, Hill B, Hollis R. 1994. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J. Clin. Microbiol. 32:407-415.
60. Miller KD, Hetrick DL, Bielefeldt DJ. 1977. Production and properties of Staphylococcus aureus (strain Newman D2C) with uniform clumping factor activity. Thromb. Res. 10:203-211. http://dx.doi.org/10.1016/0049-3848(77)90002-0.
61. Herbert S, Ziebandt AK, Ohlsen K, Schäfer T, Hecker M, Albrecht D, Novick R, Götz F. 2010. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect. Immun. 78:2877-2889. http://dx.doi.org/10.1128/IAI.00088-10.
62. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4(1):e00537-00512. http://dx.doi.org/10.1128/mBio.00537-12.
63. Hugh R, Ellis MA. 1968. The neotype strain for Staphylococcus epidermidis. Evans, Winslow 1916. Int. J. Syst. Bacteriol. 18:231-239.